CytomX Therapeutics, Inc.
CTMXBiotechnology
$2.34+2.18%As of Oct 30vs prior close
- Market cap
- $509.9M
- From 52W high
- −65.33%
- Revenue (LTM)
- $18.3M
- Net margin
- -435.21%
- Dividend yield
- 0.00%
Nomior Score
27
Steady ProfileSpeculativeBottom 13% of the scored universe
Growth35
Quality48
Value42
Momentum26
Resilience38
Growth
+19.75%revenue a year over 9 fiscal years
YE16 $15MLTM $18.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 1677% of revenue, wider by 1670 pts on a year.
Who owns it
2funds